by CytoPrevent | Jun 23, 2022 | Studies
Seth Eisenberg British Journal of Nursing (BJN), 2022, Vol 31, No 10 (Oncology Supplement) ABSTRACT Exposure to cytotoxic chemotherapy can result in acute and chronic conditions including nausea, headaches, rashes, miscarriages, infertility and genetic...
by CytoPrevent | Oct 5, 2021 | Studies
Pesqué Raphaëlle, Peyrilles Elodie, Jourdan Nathalie, Albert Odile, Sessink Paul, Madelaine Isabelle, Levert Hélène Abstract Background: Occupational exposure to cytotoxic drugs can lead to significant health problems. This study was designed to evaluate...
by CytoPrevent | Nov 15, 2020 | Studies
Pauline Claraz, Isabelle Rif, Charlotte Vert, Elina Wolff, Sophie Perriat, Anaïs Grand, Yann Cretu, Isabelle Hennebelle, Jean-Marie Canonge, Florent Puisset Abstract: Purpose: Infusion of cytotoxic drugs carries the risk of occupational exposure of healthcare...
by CytoPrevent | Oct 30, 2020 | Studies
Seth EISENBERG Abstract: USP General Chapter requires closed system drug-transfer devices (CSTDs) for hazardous drug (HD) administration where the dosage form allows, but only recommends CSTD use for compounding. Yet, recent data shows a higher percentage of usage...
by CytoPrevent | Jul 7, 2020 | Studies
Mirjam Crul, Simone Hilhorst, Oscar Breukels, Johanna R. C. Boumand’Onofrio, Percival Stubbs & Joost G. van Rooij Abstract: Many studies into surface contamination of hospital environments have demonstrated that occupational exposure to cytotoxics through...
by CytoPrevent | Jun 17, 2020 | Studies
Christopher R. Friese, PhD, RN, AOCN®, FAAN, Mandy Wong, MS, Alex Fauer, RN, BSN, Kari Mendelsohn-Victor, MPH, Martha Polovich, PhD, RN, AOCN®, and Marjorie C. McCullagh, PhD, RN, FAAOHN, FAAN Abstract: BACKGROUND: Hazardous drug exposure is an occupational...